Dozens of House representatives have taken issue with the Centers for Medicare & Medicaid Services’ (CMS’) recent repeal of a Trump-era rule granting expedited Medicare coverage to breakthrough medical devices.
In a letter penned to CMS Administrator Chiquita Brooks-LaSure last week, 61 bipartisan lawmakers wrote that they “do not support” CMS’ Nov. 12 repeal decision nor “the multiple postponements” the agency issued throughout the year as it evaluated the Medicare Coverage of Innovative Technology (MCIT) final rule.
